Gomez-Manzano C - Search Results

1

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.

Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H, Kumthekar PU, Chen CC, Aiken R, Groves MD, Ong SS, Ramakrishna R, Vogelbaum MA, Khagi S, Kaley T, Melear JM, Peereboom DM, Rodriguez A, Yankelevich M, Nair SG, Puduvalli VK, Aldape K, Gao A, López-Janeiro Á, de Andrea CE, Alonso MM, Boutros P, Robbins J, Mason WP, Sonabend AM, Stupp R, Fueyo J, Gomez-Manzano C, Lang FF, Zadeh G. Nassiri F, et al. Among authors: gomez manzano c. Nat Med. 2023 Jun;29(6):1370-1378. doi: 10.1038/s41591-023-02347-y. Epub 2023 May 15. Nat Med. 2023. PMID: 37188783 Free PMC article. Clinical Trial.

2

Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survival.

Lee HY, Srinivas H, Xia D, Lu Y, Superty R, LaPushin R, Gomez-Manzano C, Gal AM, Walsh GL, Force T, Ueki K, Mills GB, Kurie JM. Lee HY, et al. J Biol Chem. 2003 Jun 27;278(26):23630-8. doi: 10.1074/jbc.M300997200. Epub 2003 Apr 24. J Biol Chem. 2003. PMID: 12714585 Free article.

3

Overexpression of E2F-1 leads to bax-independent cell death in human glioma cells.

Mitlianga PG, Gomez-Manzano C, Kyritsis AP, Fueyo J. Mitlianga PG, et al. Int J Oncol. 2002 Nov;21(5):1015-20. Int J Oncol. 2002. PMID: 12370749

4

Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis.

Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, Liu JL, Jasti SL, Liu TJ, Conrad CA, Yung WK. Gomez-Manzano C, et al. Ann Neurol. 2003 Jan;53(1):109-17. doi: 10.1002/ana.10396. Ann Neurol. 2003. PMID: 12509854

5

Oncolytic adenoviruses for malignant glioma therapy.

Jiang H, Conrad C, Fueyo J, Gomez-Manzano C, Liu TJ. Jiang H, et al. Front Biosci. 2003 May 1;8:d577-88. doi: 10.2741/923. Front Biosci. 2003. PMID: 12700119 Review.

6

Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.

Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, Sawaya R, Curiel DT, Yung WK, Lang FF. Fueyo J, et al. J Natl Cancer Inst. 2003 May 7;95(9):652-60. doi: 10.1093/jnci/95.9.652. J Natl Cancer Inst. 2003. PMID: 12734316

7

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo.

Gomez-Manzano C, Balague C, Alemany R, Lemoine MG, Mitlianga P, Jiang H, Khan A, Alonso M, Lang FF, Conrad CA, Liu TJ, Bekele BN, Yung WK, Fueyo J. Gomez-Manzano C, et al. Oncogene. 2004 Mar 11;23(10):1821-8. doi: 10.1038/sj.onc.1207321. Oncogene. 2004. PMID: 15014451

8

Genetically modified adenoviruses against gliomas: from bench to bedside.

Gomez-Manzano C, Yung WK, Alemany R, Fueyo J. Gomez-Manzano C, et al. Neurology. 2004 Aug 10;63(3):418-26. doi: 10.1212/01.wnl.0000133302.15022.7f. Neurology. 2004. PMID: 15304571 Review.

9

Robust infectivity and replication of Delta-24 adenovirus induce cell death in human medulloblastoma.

Stolarek R, Gomez-Manzano C, Jiang H, Suttle G, Lemoine MG, Fueyo J. Stolarek R, et al. Cancer Gene Ther. 2004 Nov;11(11):713-20. doi: 10.1038/sj.cgt.7700731. Cancer Gene Ther. 2004. PMID: 15332115

10

Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.

Jiang H, Gomez-Manzano C, Alemany R, Medrano D, Alonso M, Bekele BN, Lin E, Conrad CC, Yung WK, Fueyo J. Jiang H, et al. Neoplasia. 2005 Jan;7(1):48-56. doi: 10.1593/neo.04391. Neoplasia. 2005. PMID: 15720816 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page